Pharmaceuticals distributor Cardinal Health (NYSE: CAH) reported a sharp increase in revenue and adjusted earnings for the first quarter of fiscal 2026.
Earnings Summary: Cardinal Health Q1 2026 revenue jumps 22%; raises guidance
Categories
Healthcare Services
UnitedHealth Group’s Q3 2025 earnings fall despite double-digit revenue growth
Healthcare behemoth UnitedHealth Group (NYSE: UNH) announced results for the third quarter of fiscal 2025, reporting an increase in revenues and a
Earnings Summary: HCA Healthcare Q3 adj. profit jumps on strong revenue growth
Health services behemoth HCA Healthcare, Inc. (NYSE: HCA) has reported a sharp increase in adjusted earnings for the third quarter of fiscal
Our differentiation is validated by strong, sustainable unit economics: Prenetics CEO
Prenetics Global Limited (NASDAQ: PRE), headquartered in Hong Kong, is a health sciences company active in genomics, diagnostics, and consumer health. In
Earnings Summary: Agilent (A) reports higher Q3 2025 revenue and profit
Healthcare company Agilent Technologies Inc. (NYSE: A) has reported higher revenue and adjusted earnings for the third quarter of fiscal 2025. The
Earnings Summary: Cardinal Health reports higher Q4 earnings and flat revenues
Cardinal Health (NYSE: CAH), a leading pharmaceuticals distributor, on Tuesday reported an increase in adjusted profit for the fourth quarter of 2025.
Hinge Health is all set to go public. What investors need to know
The IPO market has witnessed steady activity so far this year, despite fluctuations in momentum across months. The technology industry continues to
Earnings Summary: Henry Schein (HSIC) reports higher Q1 2025 profit
Henry Schein, Inc. (Nasdaq: HSIC), a provider of healthcare solutions to office-based dental and medical practitioners, Monday reported an increase in net income
Earnings Summary: Cigna Group (CI) reports 14% growth in Q1 2025 revenue
The Cigna Group (NYSE: CI), a healthcare company focused on medical insurance and related services, reported results for the first quarter of 2025.
Earnings: CVS Health Q1 2025 revenue and profit beat estimates
Healthcare conglomerate CVS Health Corporation (NYSE: CVS) reported higher revenues and adjusted profit for the first quarter of 2025. The results exceeded
Earnings Summary: HCA Healthcare reports higher Q1 2025 revenue and profit
HCA Healthcare, Inc. (NYSE: HCA) on Friday reported an increase in revenues and net income for the first quarter of 2025. The
Deals and R&D in focus as Johnson & Johnson gears up for Q1 earnings
For Johnson & Johnson (NYSE: JNJ), investments in its pipeline and exiting lower priority businesses remain central to its strategy in the
Earnings Summary: Highlights of HCA Healthcare’s Q4 2024 financial results
Hospital chain HCA Healthcare, Inc. (NYSE: HCA) on Friday announced financial and operating results for the fourth quarter of fiscal 2024. Fourth-quarter
What to look for when CVS Health (CVS) reports Q3 earnings
Healthcare company CVS Health Corporation (NYSE: CVS) is all set to report earnings next week, with Wall Street expecting a mixed outcome.
CVS Health to report Q2 2024 results on Wednesday. Here’s what to expect
Healthcare conglomerate CVS Health Corporation (NYSE: CVS) had a modest start to fiscal 2024, with sales and profit coming under pressure from
Earnings Summary: Organon reports financial results for Q1 2024
Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and adjusted earnings for the first quarter of 2024. First-quarter revenue
Earnings Preview: UnitedHealth (UNH) looks poised to deliver another strong quarter
After delivering a solid performance last year, UnitedHealth Group (NYSE: UNH) will be reporting first-quarter financial data next week. The healthcare conglomerate’s
PACS Group gears up for $400 million IPO. Here’s all you need to know
After a slow start to the year, the IPO market is witnessing a rush of tech and healthcare companies seeking to go
Walgreens Boots Alliance set to report earnings next week. Here’s what to expect
Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring
CVS Health Q4 2023 adj. earnings rise on higher revenues; guides FY24
Healthcare conglomerate CVS Health Corporation (NYSE: CVS) announced fourth-quarter 2023 results, reporting higher revenues and adjusted earnings. December quarter adjusted profit increased
Earnings Summary: Highlights of Centene Corp’s Q4 2023 financial results
Healthcare service provider Centene Corporation (NYSE: CNC) on Tuesday announced fourth-quarter 2023 results, reporting an increase in revenues and a fall in